Navigation Links
Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes
Date:11/9/2009

PALO ALTO, Calif., Nov. 9 /PRNewswire/ -- Genencor, a division of Danisco, has won the national "Sustainable Energy Award" from the American Institute of Chemical Engineers (AIChE) for its Accellerase® family of enzymes for cellulosic ethanol. Yesterday, Robert Davis, Chair of the AIChE Awards committee, presented the award to Landon Steele, who is Marketing Director, Biomass Enzymes and Accellerase® Product Manager, and Aaron Kelley, who is Senior Engineer, Biomass Applications and Accellerase® 1500 Project Leader, at the Honors Ceremony of the AIChE Annual Meeting at the Gaylord Opryland Hotel in Nashville, Tennessee.

The AIChE Sustainable Energy Award recognizes the critical impact of chemistry and biochemistry innovations in developing sustainable energy solutions. The American Institute of Chemical Engineers (AIChE) is the world's leading organization for chemical engineering professionals with more than 40,000 members from 93 countries. This is the first year AIChE presented a Sustainable Energy Award at its Honors Ceremony. "It's an honor for Aaron and me to accept this award from our peers on behalf of the entire Accellerase® team," said Landon Steele, who is a chemical engineer. "We're proud to be part of a company that works tirelessly to improve outcomes in carbon impact and natural resource consumption."

"Genencor is pleased to receive recognition for playing a major role in accelerating the commercialisation of cellulosic ethanol and other biofuels and biochemicals that will significantly lower greenhouse gas emissions," said Philippe Lavielle, Executive Vice President of Business Development for Genencor. "We were the first to market with an enzyme for large-scale production of fuel from biomass, and this past April we launched our second-generation flagship product, Accellerase® 1500 as well as three accessory products. We continue to innovate, and plan to release another new product in 2010."

Genencor set its vision many years ago to build the bioeconomy. "We are now seeing the results of our work being scaled up around the world, as pioneering early stage biorefineries start to come on line," says Steele. "We are supplying them at commercial scale today." A recent report by the WWF (World Wide Fund), titled Industrial biotechnology -- more than green fuel in a dirty economy?, reports that industrial biotech could potentially save the planet up to 2.5 billion tons of carbon emissions.

About Genencor

Genencor, a division of Danisco A/S, is a world leader in industrial biotechnology and a pioneer in enzyme innovation. Genencor improves process and product performance for a spectrum of industries, from biofuels, biochemicals, textiles and laundry detergents to animal nutrition and food. As part of a large global organisation, Genencor has a manufacturing and distribution network that spans more than 40 countries.

SOURCE Genencor


'/>"/>
SOURCE Genencor
Copyright©2009 PR Newswire.
All rights reserved

Related biology news :

1. American Physiological Society endorses report on random source dogs and cats
2. New American Chemical Society podcast: Tiny sea creature and a new medical adhesive
3. Despite risk, older African-Americans more likely than others to avoid flu vaccine
4. American Dietetic Association supports IOM recommendations on school meal programs
5. American Association for Cancer Research to honor leading researchers at breast cancer symposium
6. Americans concerned about heart health, but not proactive enough to prevent it
7. UF to get $64 million over 6 years to study disability prevention in older Americans
8. Nanotechnology and synthetic biology: What does the American public think?
9. Tips from the American Journal of Pathology
10. Tennessee foresters helping to return chestnuts to American forests
11. Rensselaer leads effort to replace 1 of the most widely used drugs in American hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2016)... Global Market Watch: Primarily supported by ... Banks and Academics) market is to witness a value of ... the highest Compounded Annual Growth Rate (CAGR) of 10.75% is ... analysis period 2014-2020. North America is ... Europe at 9.56% respectively. Report ...
(Date:11/14/2016)... Technology, Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), ... in challenging operating environments, announced its results for the ... a conference call to discuss these results on November ... Key Recent Accomplishments ... acquire Vislink Communication Systems. The purchase is expected to ...
(Date:6/22/2016)... -- On Monday, the Department of Homeland Security (DHS) ... for the Biometric Exit Program. The Request for Information ... explains that CBP intends to add biometrics to confirm ... States , in order to deter visa overstays, ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... DIEGO, Dec. 8, 2016  OncoSec Medical Incorporated ... developing DNA-based intratumoral cancer immunotherapies, today announced financial ... "We are delivering on our commitment ... with ImmunoPulse┬« IL-12. We are pleased with the ... combination trial, and we are focused on advancing ...
(Date:12/8/2016)... , Dec. 8, 2016 Eurofins announces the appointment of ... President of Eurofins Scientific Inc. (ESI). Mr. Murray ... proven professional and entrepreneurial experience in leading international business teams. As ... food testing market to uphold Eurofins, status as the global leader ... , ...
(Date:12/8/2016)... 8, 2016  Anaconda BioMed S.L., a pre-clinical stage ... next generation neuro-thrombectomy system for the treatment of Acute ... Jovin, MD to join its Scientific Advisory Board (SAB). ... network of scientific and clinical experts to Anaconda BioMed ... ANCD BRAIN ┬« to its clinical phase. The ...
(Date:12/8/2016)... N.J. , Dec. 8, 2016  Soligenix, ... late-stage biopharmaceutical company focused on developing and commercializing ... an unmet medical need, announced today the long-term ... with SGX942 (dusquetide), a first-in-class Innate Defense Regulator ... in head and neck cancer patients undergoing chemoradiation ...
Breaking Biology Technology: